hotspot -WSS

hotspot

author：knowledge 2025-09-27 13:10:13 - browse：8396

In a surprise move, the Food and Drug Administration has called for a meeting of outside advisers to discuss whether an Alzheimer’s drug from Eli Lilly should be approved, even as many outsiders expected the medicine to receive regulatory clearance this month.

The drug, donanemab, succeeded in its Phase 3 trial, resulting in a 35% slowing of Alzheimer’s disease progression versus placebo. But Lilly on Friday said that the FDA expects to call a meeting of an advisory committee to review the trial, saying that the agency had told the company “it wants to further understand topics related to evaluating the safety and efficacy of donanemab, including the safety results in donanemab-treated patients and the efficacy implications of the unique trial design” of the study.

A date for the meeting has not been set yet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： 'Weather

WSS

What AstraZeneca

Teacher posts viral 'school supply rant' with advice for parents

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

House GOP plan to stem drug shortages differs from Democrats’

China demands US invite Hong Kong leader to economic meeting, adding to strains over crackdown

hotspot

hotspot

focus

Novavax promises a turnaround & Lilly roils the obesity market

STAT reporters are Pulitzer Prize finalists for investigative reporting

DIEP, the 'gold standard' of breast reconstruction, is under threat

What AstraZeneca

Trump demands the U.S. pay no more for drugs than other countries … again

China demands US invite Hong Kong leader to economic meeting, adding to strains over crackdown

Apple is now the first public company to be valued at $3 trillion

ALS treatment from Biogen, Ionis fails in study

Malaria cases in Florida and Texas: Here’s what you need to know

China demands US invite Hong Kong leader to economic meeting, adding to strains over crackdown

hotspot

Oak Street deal isn't the answer to health care's woes

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

As H5N1 spreads in cows, experts warn against drinking raw milk

9 mass shootings over the weekend rock US cities, leaving 5 dead, 56 injured

Young Chinese opt out of the rat race and pressures at home to pursue global nomad lifestyle

Lilly’s weekly insulin works as well as daily products, new studies show

focus

focus

explore

entertainment